Evidence map›Paper›PMID 23589623›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis.

Sandeep K Raghuwanshi, Nikia Smith, Elizabeth J Rivers, Ariel J Thomas, Natalie Sutton, Yuhui Hu, Somnath Mukhopadhyay, Xiaoxin L Chen, TinChung Leung, Ricardo M Richardson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. The GRKs Reactome: Role in Cell Biology and Pathology.International journal of molecular sciences · 2021
    Review
  8. Frontiers in oncology · 2021
    Article
  9. Differential Regulation of GPCRs-Are GRK Expression Levels the Key?Frontiers in cell and developmental biology · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. The Role of G Protein-coupled Receptor Kinases in Cancer.International journal of biological sciences · 2018
    Review
  16. Article
  17. Review
  18. Prognostic value of decreased GRK6 expression in lung adenocarcinoma.Journal of cancer research and clinical oncology · 2016
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sandeep K RaghuwanshiDepartment of Biology, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.
Nikia Smith
Elizabeth J Rivers
Ariel J Thomas
Natalie Sutton
Yuhui Hu
Somnath Mukhopadhyay
Xiaoxin L Chen
TinChung Leung
Ricardo M Richardson
North Carolina Central University · US

Funding

ROLES OF INFLAMMATION AND ANDROGEN METABOLISM IN PROSTATE CANCER DISPARITYP20MD000175 · NIMHD · NORTH CAROLINA CENTRAL UNIVERSITY · PI KIMBRO, KEVIN SEAN · 2002 to 2016
$15.6M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156735 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2010 to 2021
$13.0M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156733 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAJOR, MICHAEL BENJAMIN · 2010 to 2020
$9.7M
MELANOMA GROWTH STIMULATORY ACTIVITYR01CA034590 · NCI · VANDERBILT UNIVERSITY · PI RICHMOND, ANN · 1986 to 2017
$5.2M
Regulation of Chemokine Mediated Leukocyte FunctionsR01AI038910 · NIAID · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2002 to 2011
$2.3M
REGULATION OF HUMAN INTERLEUKIN-8 RECEPTORSR29AI038910 · NIAID · DUKE UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 1996 to 2000
$107k
NCI NIH HHS CA156735NCI NIH HHS R01 CA034590NCI NIH HHS U54 CA156733NCI NIH HHS U54 CA156735NIAID NIH HHS AI38910NIAID NIH HHS R01 AI038910NIAID NIH HHS R29 AI038910NIMHD NIH HHS P20 MD000175NIMHD NIH HHS P20 MD00175
6 · The paper itself

Abstract

G protein-coupled receptor kinases (GRKs) phosphorylate the activated form of G protein-coupled receptors leading to receptor desensitization and downregulation. We have recently shown that the chemokine receptor, CXCR2, couples to GRK6 to regulate cellular responses including chemotaxis, angiogenesis, and wound healing. In this study, we investigate the role of GRK6 in tumorigenesis using murine models of human lung cancer. Mice deficient in GRK6 (GRK6(-/-)) exhibited a significant increase in Lewis lung cancer growth and metastasis relative to control littermates (GRK6(+/+)). GRK6 deletion had no effect on the expression of proangiogenic chemokine or vascular endothelial growth factor, but upregulated matrix metalloproteinase (MMP)-2 and MMP-9 release, tumor-infiltrating PMNs, and microvessel density. Because β-arrestin-2-deficient (βarr2(-/-)) mice exhibited increased Lewis lung cancer growth and metastasis similar to that of GRK6(-/-), we developed a double GRK6(-/-)/βarr2(-/-) mouse model. Surprisingly, GRK6(-/-)/βarr2(-/-) mice exhibited faster tumor growth relative to GRK6(-/-) or βarr2(-/-) mice. Treatment of the mice with anti-CXCR2 Ab inhibited tumor growth in both GRK6(-/-) and GRK6(-/-)/βarr2(-/-) animals. Altogether, the results indicate that CXCR2 couples to GRK6 to regulate angiogenesis, tumor progression, and metastasis. Deletion of GRK6 increases the activity of the host CXCR2, resulting in greater PMN infiltration and MMP release in the tumor microenvironment, thereby promoting angiogenesis and metastasis. Because GRK6(-/-)/βarr2(-/-) showed greater tumor growth relative to GRK6(-/-) or βarr2(-/-) mice, the data further suggest that CXCR2 couples to different mechanisms to mediate tumor progression and metastasis.

Indexed as

AnimalsArrestinsbeta-Arrestin 2beta-ArrestinsCarcinoma, Lewis LungCell Line, TumorChemotaxisDisease ProgressionDown-RegulationGenotypeG-Protein-Coupled Receptor KinasesLung NeoplasmsMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceMice, KnockoutARRB2 protein, humanArrb2 protein, mouseArrestinsbeta-Arrestin 2beta-ArrestinsG-protein-coupled receptor kinase 6G-Protein-Coupled Receptor KinasesMatrix Metalloproteinase 2Matrix Metalloproteinase 9Mmp2 protein, mouseMmp9 protein, mousePhenylurea CompoundsReceptors, Interleukin-8BSB 225002

Identifiers

PMID23589623
PMCPMC3646980
OpenAlexW2169236319

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.